The role of SARS-CoV-2 accessory proteins in immune evasion

Biomed Pharmacother. 2022 Dec:156:113889. doi: 10.1016/j.biopha.2022.113889. Epub 2022 Oct 17.

Abstract

Many questions on the SARS-CoV-2 pathogenesis remain to answer. The SARS-CoV-2 genome encodes some accessory proteins that are essential for infection. Notably, accessory proteins of SARS-CoV-2 play significant roles in affecting immune escape and viral pathogenesis. Therefore SARS-CoV-2 accessory proteins could be considered putative drug targets. IFN-I and IFN-III responses are the primary mechanisms of innate antiviral immunity in infection clearance. Previous research has shown that SARS-CoV-2 suppresses IFN-β by infecting host cells via ORF3a, ORF3b, ORF6, ORF7a, ORF7b, ORF8, and ORF9b. Furthermore, ORF3a, ORF7a, and ORF7b have a role in blocking IFNα signaling, and ORF8 represses IFNβ signaling. The ORF3a, ORF7a, and ORF7b disrupt the STAT1/2 phosphorylation. ORF3a, ORF6, ORF7a, and ORF7b could prevent the ISRE promoter activity. The main SARS-CoV-2 accessory proteins involved in immune evasion are discussed here for comprehensive learning on viral entry, replication, and transmission in vaccines and antiviral development.

Keywords: Accessory proteins; Immune evasion; ORF; SARS-CoV-2.

Publication types

  • Review

MeSH terms

  • Antiviral Agents
  • COVID-19*
  • Humans
  • Immune Evasion
  • Interferon-beta / genetics
  • SARS-CoV-2*

Substances

  • Interferon-beta
  • Antiviral Agents